The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 05, 2021

Filed:

Sep. 10, 2019
Applicant:

Risen (Suzhou) Pharma Tech Co. Ltd., Jiangsu, CN;

Inventors:

Jiasheng Lu, Shanghai, CN;

Jiamin Gu, Suzhou, CN;

Dongdong Wu, Suzhou, CN;

Gang Chen, Suzhou, CN;

Chengyong Sun, Suzhou, CN;

Xiang Ji, Suzhou, CN;

Lin Wang, Suzhou, CN;

Feng Zhou, Suzhou, CN;

Xiuchun Zhang, Suzhou, CN;

Xianqi Kong, Dollard-des-Ormeaux, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 19/20 (2006.01); A61P 35/00 (2006.01); A61K 31/7076 (2006.01); A61K 9/00 (2006.01); C07H 19/16 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7076 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 39/3955 (2013.01); C07H 19/16 (2013.01); C07H 19/20 (2013.01);
Abstract

CD73 (also known as ecto-5'-nucleotidase) inhibitor compounds are provided, as well as compositions and uses thereof for treating or preventing CD73-associated or related diseases, disorders and conditions, including cancer- and immune-related disorders. CD73 inhibitor compounds include compounds having the structure set forth in Formula I and pharmaceutically acceptable esters or salts thereof.


Find Patent Forward Citations

Loading…